Quantcast

Keystone Today

Tuesday, April 22, 2025

FDA conducted second highest number of inspections on Biologics companies in Pennsylvania during March

Webp ijw6s7vbfr36c32lki2m95inya4m

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website

In March, two Biologics companies received two FDA inspections in Pennsylvania, according to the U.S. Food and Drug Administration (FDA).

This was the second highest number of inspections per type of company made by the FDA in Pennsylvania, equalling 16.7% of all inspections in March.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Pennsylvania During March
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products2
Compliance: Devices1
Drug Quality Assurance1
Food Composition, Standards, Labeling and Econ2
Foodborne Biological Hazards5
Monitoring of Marketed Animal Drugs, Feed, and Devices2
Postmarket Assurance: Devices1
Technical Assistance: Food and Cosmetics1

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS